[Important matters]
XinTong Medical-B (02160): Vitaflow Liberty receives CE mark approval
Goodwill B (02256): The FGFR4 inhibitor ipagotinib was certified as an orphan drug by the US FDA
China Biopharmaceutical (01177): Class 1 innovative drug “TQA3038 (siRNA)” completed phase I clinical research
Huatai Securities (06886) plans to cash out approximately US$1,793 million through a merger sale of its AssetMark shares
China Xincheng (01278) subsidiary plans to invest 50 million yuan to acquire 30% of Meidi Pension Service (Shanghai)'s shares
[Financial Report Data]
Fuyao Glass (03606)'s net profit for the first quarter was 1,388 billion yuan, up 51.76% year on year
Kanglong Chemical (03759) announced first-quarter results, net profit of about 231 million yuan, a year-on-year decrease of 33.8%
ZTE (00763) announced first-quarter results, net profit of about 2,741 billion yuan, up 3.74% year-on-year
Longyuan Electric Power (00916) announced first-quarter results, net profit of 2,482 billion yuan, up 2.59% year-on-year
China Aluminum (02600) announced first-quarter results, net profit of about 2.23 billion yuan, a year-on-year increase of 23.01%
CNOOC (00883) announced first-quarter results, net profit of 39.719 billion yuan, an increase of 23.7% year-on-year
Xintian Green Energy (00956) announced first-quarter results, net profit of about 832 million yuan, a year-on-year decrease of 0.89%
[Buy/Increase or Decrease Holds]
Hang Seng Bank (00011) spent HK$61.1091 million to repurchase 600,000 shares
Kanglong Chemical (03759) plans to repurchase 200 million to 300 million yuan of A-shares
CGN New Energy (01811) plans to use up to HK$157 million to repurchase no more than 643.624 million shares of the company
For more details, please refer to Zhitong Financial Network ()